118 related articles for article (PubMed ID: 25311663)
1. Structure-based lead discovery for protein kinase C zeta inhibitor design by exploiting kinase-inhibitor complex crystal structure data and potential therapeutics for preterm labour.
Shao QC; Zhang CJ; Li J
Arch Pharm Res; 2014 Oct; ():. PubMed ID: 25311663
[TBL] [Abstract][Full Text] [Related]
2. Characterization of PDK2 activity against protein kinase B gamma.
Hodgkinson CP; Sale EM; Sale GJ
Biochemistry; 2002 Aug; 41(32):10351-9. PubMed ID: 12162751
[TBL] [Abstract][Full Text] [Related]
3. Structure-based grafting and identification of kinase-inhibitors to target mTOR signaling pathway as potential therapeutics for glioblastoma.
Cui YH; Chen J; Xu T; Tian HL
Comput Biol Chem; 2015 Feb; 54():57-65. PubMed ID: 25625417
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
Lu H; Chang DJ; Baratte B; Meijer L; Schulze-Gahmen U
J Med Chem; 2005 Feb; 48(3):737-43. PubMed ID: 15689157
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin-sensitive phosphorylation of PKC on a carboxy-terminal site by an atypical PKC complex.
Ziegler WH; Parekh DB; Le Good JA; Whelan RD; Kelly JJ; Frech M; Hemmings BA; Parker PJ
Curr Biol; 1999 May; 9(10):522-9. PubMed ID: 10339425
[TBL] [Abstract][Full Text] [Related]
7. Protein Kinase C (PKC)ζ Pseudosubstrate Inhibitor Peptide Promiscuously Binds PKC Family Isoforms and Disrupts Conventional PKC Targeting and Translocation.
Bogard AS; Tavalin SJ
Mol Pharmacol; 2015 Oct; 88(4):728-35. PubMed ID: 26199377
[TBL] [Abstract][Full Text] [Related]
8. Atypical PKCzeta is involved in RhoA-dependent mitogenic signaling by the P2Y(12) receptor in C6 cells.
Van Kolen K; Slegers H
FEBS J; 2006 Apr; 273(8):1843-54. PubMed ID: 16623718
[TBL] [Abstract][Full Text] [Related]
9. 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ.
Fröhner W; Lopez-Garcia LA; Neimanis S; Weber N; Navratil J; Maurer F; Stroba A; Zhang H; Biondi RM; Engel M
J Med Chem; 2011 Oct; 54(19):6714-23. PubMed ID: 21863889
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening of protein kinase C inhibitors from natural product library to modulate general anaesthetic effects.
Zhao J; Zhou C
Nat Prod Res; 2015; 29(6):589-91. PubMed ID: 25190070
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
Courage C; Budworth J; Gescher A
Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
[TBL] [Abstract][Full Text] [Related]
12. Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer.
Nazarenko I; Jenny M; Keil J; Gieseler C; Weisshaupt K; Sehouli J; Legewie S; Herbst L; Weichert W; Darb-Esfahani S; Dietel M; Schäfer R; Ueberall F; Sers C
Mol Cancer Res; 2010 Jun; 8(6):919-34. PubMed ID: 20501645
[TBL] [Abstract][Full Text] [Related]
13. Structure-based modelling, scoring, screening, and in vitro kinase assay of anesthetic pkc inhibitors against a natural medicine library.
Shi BX; Chen FR; Sun X
SAR QSAR Environ Res; 2017 Feb; 28(2):151-163. PubMed ID: 28235389
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-zeta mediates retinal degeneration in response to TNF.
Liang H; Baudouin C; Behar-Cohen F; Crisanti P; Omri B
J Neuroimmunol; 2007 Feb; 183(1-2):104-10. PubMed ID: 17207538
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of pim1 kinase in complex with a pyrido[4,3-d]pyrimidine derivative suggests a unique binding mode.
Lee SJ; Han BG; Cho JW; Choi JS; Lee J; Song HJ; Koh JS; Lee BI
PLoS One; 2013; 8(7):e70358. PubMed ID: 23936194
[TBL] [Abstract][Full Text] [Related]
16. A new target for an old drug: identifying mitoxantrone as a nanomolar inhibitor of PIM1 kinase via kinome-wide selectivity modeling.
Wan X; Zhang W; Li L; Xie Y; Li W; Huang N
J Med Chem; 2013 Mar; 56(6):2619-29. PubMed ID: 23442188
[TBL] [Abstract][Full Text] [Related]
17. Commiphora myrrha stimulates insulin secretion from β-cells through activation of atypical protein kinase C and mitogen-activated protein kinase.
Al-Romaiyan A; Masocha W; Oyedemi S; Marafie SK; Huang GC; Jones PM; Persaud SJ
J Ethnopharmacol; 2023 Feb; 302(Pt B):115937. PubMed ID: 36410575
[TBL] [Abstract][Full Text] [Related]
18. A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Czeta (PKCzeta ) and PKC-related kinase 2 by PDK1.
Balendran A; Biondi RM; Cheung PC; Casamayor A; Deak M; Alessi DR
J Biol Chem; 2000 Jul; 275(27):20806-13. PubMed ID: 10764742
[TBL] [Abstract][Full Text] [Related]
19. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
Ranganathan S; Wang Y; Kern FG; Qu Z; Li R
Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
